Nanomedicine is a new modality for cancer diagnosis and therapy and may change the landscape of oncology. In this presentation I will mainly present the design and synthesis of size controlled silica nanoconjugates and their applications as drug delivery nanomedicine, and discuss their application in various fundamental studies, such as cellular uptake, biodistribution, tumor tissue penetration, retention and inhibition. I will cover several other topics related to anticancer nanomedicine, such as development of conjugated polymeric particles via drug-initiated polymerization of lactide, recent development of chain-shattering polymeric therapeutics and high loading polymer/drug nanocrystals.

Formulation of nanoparticles through controlled chemistry for drug delivery application

251st National Meeting (2016)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.